InvestorsHub Logo
Followers 30
Posts 3313
Boards Moderated 0
Alias Born 08/21/2015

Re: misiu143 post# 223789

Thursday, 08/31/2023 7:44:05 AM

Thursday, August 31, 2023 7:44:05 AM

Post# of 233147
“Ok , medical person to medical person ,what are you trying to tell me …?????”

First…The drug failed CD12. The subpopulation analysis, ordered by a felon and conducted by trusted Amarex, demonstrated promise but still was not statistically significant. Yes, there are anecdotal stories about leronlimab’s success in individual patients but that’s yet to be proven in the gold standard of trials, an RCT.

Second…the FOIA request disclosed everyone involved in releasing the letter, including their names. Whether or not they work in the same department means nothing.

Third…COVID is a dead indication for CYDY. There’s no reason even discussing it. Focus on cancer and NASH.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News